Physician profile
Shim Ching
NPI 1184670689
$48,689.34
in general payments reported to CMS, 2019-2025
20 companies · $2,612 in 2025
The $2,612 reported for 2025 was more than what 87% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $680 · 2021: $946 · 2022: $6,913 · 2023: $11K · 2024: $4,408 · 2025: $2,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,227 · Long Term Medical Supply Or Device Loan: $326 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,176.23 |
| Food and Beverage | $4,227.03 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Education | $207.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28,784.69 | 2019-2022 | |
| Abbvie INC. | $16,433.72 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Merz North America, INC. | $1,123.85 | 2019-2025 | |
| Revance Therapeutics, INC. | $510.77 | 2024-2025 | Daxxify, Daxi |
| Integra Lifesciences Corporation | $325.80 | 2025 | Durasorb Monofilament Mesh |
| Surgical Innovation Associates, INC. | $323.29 | 2022 | |
| Galderma Laboratories, L.P. | $314.07 | 2019-2025 | Dysport |
| Sientra, INC. | $210.88 | 2019 | |
| Motiva USA, LLC | $145.07 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $110.03 | 2022-2023 | Seglentis, Livalo |
| Tela Bio, INC. | $87.45 | 2024 | Ovitex 2s |
| Mentor Worldwide LLC | $74.11 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Karl Storz Endoscopy-America | $57.75 | 2021-2022 | |
| Coopersurgical, INC. | $57.02 | 2019-2022 | |
| Apollo Endosurgery US INC | $33.65 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $23.71 | 2022 | |
| Novo Nordisk INC | $22.76 | 2023 | Wegovy |
| Kls-Martin L.P. | $19.93 | 2023 | |
| Davol INC. | $15.70 | 2022 | |
| Heron Therapeutics, INC. | $15.09 | 2024 | Aponvie |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shim Ching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.